Chronic myelogenous leukemia (CML) is an important hematological tumor that is characterized by the BCR-ABL chimera gene and occurs in 15 to 20% of adults with leukemia [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.